| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |